Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | SON-1010 |
Trade Name | |
Synonyms | SON 1010|SON1010 |
Drug Descriptions |
SON-1010 is a recombinant variant of IL-12 linked to an albumin-binding domain, which potentially induces enhanced antitumor immune response (Cancer Res (2023) 83 (8_Supplement): CT245). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Atezolizumab + SON-1010 | Atezolizumab SON-1010 | 0 | 1 |
SON-1010 | SON-1010 | 0 | 2 |